2021 BRN Discussion, page-573

In January, 2020 I predicted that the share price for BRN by the end of the year would be 50 cents based on all of the then available information which included the possibility of a first commercial deal.

In the end BRN got the first commercial deal done with Renesas and also landed NASA as an EAP.

I claimed my prediction of 50 cents by years end.

I recently predicted $1.00 by end 2021 based on the idea that the only commercial deal throughout 2021 would be Renesas and the revenue it would bring to BRN.

The price of BRN shares has dropped along with the rest of the tech sector to 46 cents.

Apart from the fact that the share price has dropped what facts have altered or changed to justify abuse of other shareholders and company’s management.

Has there been any information from any quarter that throws doubt on the statements made by BRN as to the technical details of its AKIDA technology.

Rather than there being doubts about the AKIDA technology in the last week BRN has had validation of AKIDA technology by an independent third party in the form of NaNose a Bill and Melinda Gates Foundation funded company.

If anyone has any solid facts that would justify the behaviour they would have by now been posted. They have not been posted so nothing has changed.

If like myself you are invested in BRN because you see the long term potential of AKIDA technology the current fluctuations in the share price will be nothing more than part of the journey.

Management has not changed. The strong capital reserves have not changed. The technology has not changed. Income of over $1 million dollars was received in January, 2021 and notified as part of the 4C documentation. Progress regarding NaNose has become available.

The abuse of others and BRN makes no logical sense.

My opinion only DYOR.